Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.
Brandy Box-Noriega
Kaiser Permanente
CA
United States
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
23
TOTAL CITATIONS
1
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Phase II Trial of Cediranib in Combination with Cisplatin and Pemetrexed in Chemo Naive Patients with Unresectable Malignant Pleural Mesothelioma (SWOG S0905, NCT01064648)
Number of pages: 27
Posted: 09 Oct 2018
Anne Tsao
,
Jieling Miao
,
Ignacio I. Wistuba
,
Nicholas J. Vogelzang
,
John Heymach
,
Frank Fossella
,
Charles Lu
,
Mario Velasco
, Brandy Box-Noriega,
James Hueftle
,
Shirish Gadgeel
,
Mary Redman
,
David Gandara
and
Karen Kelly
University of Texas at Houston - MD Anderson Cancer Center, SWOG Statistical Center, University of Texas at Houston - Department of Translational Molecular Pathology, US Oncology Comprehensive Cancer Centers of Nevada, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, Cancer Care Specialists of Illinois, Kaiser Permanente, Montana Cancer Consortium, University of Michigan at Ann Arbor - Medical School, SWOG Statistical Center, University of California, Davis - School of Medicine and University of California, Davis - School of Medicine
Downloads
23
(983,634)
Citation
1
View PDF
Download
Abstract:
mesothelioma, cediranib, cisplatin, pemetrexed, SWOG0905
Feedback